Treating M
Internal Medicine
2022-05-16

Treating Mild Chronic Hypertension in Pregnancy Associated With Better Outcomes

In pregnant women with mild chronic hypertension, a strategy of targeting blood pressure to <140/90 mm Hg was associated with better pregnancy outcomes compared with a strategy of reserving treatment only for women with severe hypertension, with no increase in the risk of small-for-gestational-age birth weight, according to a study published in The New England Journal of Medicine. “Chronic hypertension causes serious and life-threatening complications for pregnant women and their babies,” said Alan Tita, MD, Marnix E. Heersink School of Medicine, University of Alabama at Birmingham, Birming...

Study high
Internal Medicine
2022-05-13

Study highlights possible ongoing microvascular/endothelial dysfunction in pathogenesis of post...

Findings from a study published in Blood Advances suggest possible ongoing microvascular/endothelial...

Virtual Ca
Internal Medicine
2022-05-11

Virtual Cardiac Rehabilitation Produces Similar Results as In-Person Treatment

Virtual and hybrid cardiac rehabilitation services produced similar improvements in patient function...

Videos from category: Cardiology

Atrial fib
19:010

Atrial fibrillation guidelines into clinical practice

EHRA 2022
Recent dev
7:02

Recent developments of the conduction system pacing

EHRA 2022
Conduction
7:07

Conduction system pacing: ready for prime time?

EHRA 2022
What do ne
7:17

What do new guidelines tell us about conduction system pacing?

EHRA 2022

Videos from category: Dermatology

Psoriasis
6:51

Psoriasis is a systemic disease

EADV 2020
New non-al
6:36

New non-allergenic, anti-inflammatory fragrance could be game changer for dry skin sufferers

EADV 2020
New Resear
4:08

New Research Reveals that Risky Sexual Behaviour and STIs are on the Rise Despite COVID-19 Pandemic

EADV 2020
New eviden
7:47

New evidence shows that systemic inflammation in psoriasis can be treated orally with a non-living strain of a commensal microbe

EADV 2020

Videos from category: Diabetology

Liraglutid
13:26

Liraglutide for Weight Management in the Real World

The role o
10:22

The role of GLP-1 receptor agonists in weight reduction and cardiovascular risk reduction

Clinical I
8:59

Clinical Impact of Liraglutide as a Treatment of Obesity

Associatio
2:59

Associations of hypoglycaemia and glycaemic variability with cardiac arrhythmias using a long-term monitoring approach in insulin-treated patients with type 2 diabetes

EASD 2021

Videos from category: Gastroenterology

Duodenal m
11:01

Duodenal mucosal resurfacing shown to discontinue insulin treatment in majority of type 2 diabetes patients and aid weight loss

UEG 2020
Allergy-re
7:48

Allergy-related diseases and IBS

UEG 2020
A Next-Gen
3:06

A Next-Generation, Dual-Action Anti-Integrin Therapy for IBD

ECCO 2020
How to seq
2:20

How to sequence advanced therapies in IBD

ECCO 2020

Videos from category: Hematology

Risks for
5:01

Risks for Hospitalization and Death Among Patients with Blood Disorders from the ASH RC COVID-19 Registry for Hematology

ASH 2021
Novelties
8:35

Novelties in the treatment of myelofibrosis and polycythemia vera 2021

ASH 2021
Novelties
12:44

Novelties in the treatment of multiple myeloma 2021

ASH 2021
Antibody R
7:02

Antibody Response to Vaccination with Myeloid and Lymphoid Neoplasms

ASH 2021

Videos from category: Internal Medicine

Important
8:39

Important messages from EULAR2021: Impact of air pollution on RA flares, effect of COVID-19 on RA care, osteoporosis care of men

EULAR 2021
What is th
14:04

What is the role of transdermal fentanyl patches in management of cancer pain?

PAINWeek 2020
Which are
4:59

Which are the most promising new medications in phase 3 clinical trials for the treatment of painful large joint arthritis?

PAINWeek 2020
Optimising
8:42

Optimising the monitoring and treatment of SSc-ILD

EULAR 2020

Videos from category: Oncology

Paradigm s
12:05

Paradigm shift in the early NSCLC? The role of ICIs in the adjuvant treatment

The role o
5:58

The role of immune checkpoint inhibitors and VEGF TKIs in the adjuvant treatment of renal cell carcinoma

How will t
9:43

How will the current therapeutic options change the treatment of RCC in the daily practice?

Treatment
11:50

Treatment intensification in the treatment of prostate cancer

Videos from category: Psychiatry

Novel Phar
8:13

Novel Pharmacotherapeutic Strategies for Regaining Control over Alcohol Intake in Alcohol Use Disorder

EPA 2021
Meeting th
15:41

Meeting the challenges of schizophrenia care during the COVID-19 pandemic

EPA 2021
Consequenc
7:54

Consequences of COVID-19 Outbreak on Mental Health

EPA 2021
Obstetric
6:010

Obstetric Complications: The Forgotten Risk Factor for Schizophrenia

EPA 2021

Videos from category: Respiratory

The digita
11:38

The digital age: The future of respiratory medicine

ERS 2021
Pulmonary
7:05

Pulmonary hypertension and interstitial pulmonary fibrosis

ERS 2021
ERS/EAACI
8:50

ERS/EAACI statement on adherence to international adult asthma guidelines

ERS 2021

Videos from category: Urology

Balancing
13:20

Balancing efficacy and quality of life measurements among metastatic renal cell carcinoma studies

EAU 2021

Suggested videos

By Author
By Topic
By Congress
4:21
Highlights of the 17th St. Gallen International Breast Cancer Conference
St. Gallen BCC 2021
11:06
IMpassion031: Results from a phase III study of neoadjuvant atezolizumab + chemotherapy in early triple-negative breast cancer
ESMO 2020
7:07
KEYNOTE-024 5-year OS update: first-line pembrolizumab vs platinum-based chemotherapy in patients with metastatic NSCLC and PD-L1 tumor proportion score ≥50%
ESMO 2020
13:09
A Polypill for Primary Prevention of Cardiovascular Disease in Intermediate Risk People: Results of the International Polycap Study (TIPS)-3
AHA 2020
6:09
PARADISE-MI: Prospective Arni Versus Ace Inhibitor Trial To Determine Superiority In Reducing Heart Failure Events After Myocardial Infarction
ACC 2021
11:15
EXPLORER-HCM: Efficacy and Safety of Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
ESC 2020
15:58
2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease
ESC 2020
8:49
First safety and efficacy results of PRADO: A phase II study of personalized response-driven surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in resectable stage III melanoma
ASCO 2020
16:51
Detailed summary of the Consensus Session of the SG-BCC 2021
St. Gallen BCC 2021
9:28
Trifluridine/tipiracil or regorafenib in refractory metastatic colorectal cancer patients: An AGEO prospective “real life” study
ASCO 2020
7:46
Inspiration-S Double Blind Randomized Controlled Trial: Atorvastatin Versus Placebo In Critically-ill Patients With Covid-19
ACC 2021
7:44
Summary of clinical and scientific topics discussed at EASD 2020 congress
EASD 2020
6:41
The Vital Rhythm Trial: Omega-3 Fatty Acid and Vitamin D Supplementation in the Primary Prevention of Atrial Fibrillation
AHA 2020
11:38
ESH-ISH 2021 Late-Breakers Session
ESH-ISH 2021
14:31
ESC Gold Medal 2020 Winner: Kari Stefansson
ESC 2020
4:08
New Research Reveals that Risky Sexual Behaviour and STIs are on the Rise Despite COVID-19 Pandemic
EADV 2020
14:49
The role of cancer immunotherapy in the treatment of patients with early triple negative breast cancer
St. Gallen BCC 2021
15:49
Hypertension Guidelines: Do They Vary Across the World as Much as My Blood Pressure Has Today?
ACC 2021
11:28
Effects of empagliflozin on physical activity and compensatory appetite responses in people with type 2 diabetes: the SEESAW trial
EASD 2020
9:01
A Three-arm N-of-1 Trial With Statin, Placebo and Tablet Free Periods, to Verify Side Effects and Identify Their Cause: The SAMSON Trial
AHA 2020
17:43
Recognizing and Addressing Risk in Patients with HR-positive, HER2-negative Early Breast Cancer
St. Gallen BCC 2021
6:55
Relatlimab plus nivolumab versus NIVO in first-line advanced melanoma: Primary phase III results from RELATIVITY-047
ASCO 2021
4:48
PRADA Trial: Prevention Of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: Long-term Follow-up Of A 2 X 2 Factorial, Randomized, Placebo-controlled, Double-blind Clinical Trial Of Candesartan And Metoprolol
ACC 2021
9:11
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study
EHA 2020
6:13
Breast cancer highlights from ESMO2020
ESMO 2020
9:42
De-escalation of early breast cancer therapy: Umberto Veronesi’s legacy
St. Gallen BCC 2021
4:59
Which are the most promising new medications in phase 3 clinical trials for the treatment of painful large joint arthritis?
PAINWeek 2020
5:09
ADAPTABLE Study: Aspirin Dosing: A Patient-centric Trial Assessing Benefits And Long-term Effectiveness Trial
ACC 2021
8:42
Optimising the monitoring and treatment of SSc-ILD
EULAR 2020
Search by Scientific Content
Search by Congress
Search:
Date
Filters:
Atrial fib
19:010
Title Description

Atrial fibrillation guidelines into clinical practice

Presenter: Daniel Scherr
Cardiology
EHRA 2022
Recent dev
7:02
Title Description

Recent developments of the conduction system pacing

Presenter: Hung-Fat Tse
Cardiology
EHRA 2022
Conduction
7:07
Title Description

Conduction system pacing: ready for prime time?

Presenter: Mauro Biffi
Cardiology
EHRA 2022
What do ne
7:17
Title Description

What do new guidelines tell us about conduction system pacing?

Presenter: Michael Glikson
Cardiology
EHRA 2022
Antithromb
5:33
Title Description

Antithrombotic Approaches to Reduce the Risk of Secondary Event in CAD and PAD

Presenter: Marc P. Bonaca
Cardiology
ACC 2022
Results fr
9:16
Title Description

Results from the EMPULSE Trial

Presenter: Mikhail Kosiborod
Cardiology
ACC 2022
Effect of
3:03
Title Description

Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk - The SCORED Trial

Presenter: Deepak Bhatt
Cardiology
ACC 2022
Protecting
9:16
Title Description

Protecting comorbid patients with atrial fibrillation from stroke

Presenter: John Camm
Cardiology
EHRA 2022
Bentracima
3:16
Title Description

Bentracimab Immediately and Significantly Reverses the Antiplatelet Effects of Ticagrelor in Older People

Presenter: Deepak Bhatt
Cardiology
ACC 2022
EHRA scien
11:56
Title Description

EHRA scientific documents 2022

Presenter: Cecilia Linde
Cardiology
EHRA 2022
Guidance i
6:01
Title Description

Guidance in Heart Failure Care at ACC 2022

Presenter: David E. Lanfear
Cardiology
ACC 2022
How to red
5:41
Title Description

How to reduce limb events including amputations in our patients?

Presenter: Manesh Patel
Cardiology
ACC 2022
Updated Cu
8:24
Title Description

Updated Cumulative Results of Treatment With Mavacamten From the EXPLORER-LTE Cohort of the MAVA-LTE Study

Presenter: Florian Rader
Cardiology
ACC 2022
Highlights
10:33
Title Description

Highlights of the San Antonio Breast Cancer Symposium 2021

Presenter: Virginia G. Kaklamani
Oncology : Breast Cancer
SABCS 2021
Novelties
8:35
Title Description

Novelties in the treatment of myelofibrosis and polycythemia vera 2021

Presenter: Srdan Verstovsek
Hematology
ASH 2021
Risks for
5:01
Title Description

Risks for Hospitalization and Death Among Patients with Blood Disorders from the ASH RC COVID-19 Registry for Hematology

Presenter: Lisa K. Hicks
Hematology
ASH 2021

Lectures

Carfilzomi
6:49

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis Results from the Randomized, Open-Label, Phase 3 Study Candor

Presenter: Saad Z. Usmani
Hematology
Inhibition
6:22

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease: Results from the Phase 3 Cardinal Study

Presenter: Alexander Röth
Hematology
The QUAZAR
8:20

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia in First Remission

Presenter: Andrew H. Wei
Hematology
Validation
7:11

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Presenter: David A. Williams
Hematology
A Randomiz
4:40

A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk First Relapse of B-ALL in Children and Adolescents/Young Adults Demonstrates Superior Efficacy and Tolerability of Blinatumomab

Presenter: Patrick A. Brown
Hematology
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
Cardiology
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
Cardiology
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
Cardiology
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
Cardiology
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
Cardiology
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients

Presenter: Andreas Goette
Cardiology
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Cardiology
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
Cardiology
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
Cardiology
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Cardiology
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
Cardiology
Paradigm s
12:05
Title Description

Paradigm shift in the early NSCLC? The role of ICIs in the adjuvant treatment

Presenter: Federico Cappuzzo
Oncology
How will t
9:43
Title Description

How will the current therapeutic options change the treatment of RCC in the daily practice?

Presenter: Camillo Porta
Oncology
The role o
5:58
Title Description

The role of immune checkpoint inhibitors and VEGF TKIs in the adjuvant treatment of renal cell carcinoma

Presenter: David F. McDermott
Oncology
Treatment
11:50
Title Description

Treatment intensification in the treatment of prostate cancer

Presenter: Oliver Sartor
Oncology
Pembrolizu
16:35
Title Description

Pembrolizumab as post nephrectomy adjuvant therapy for patients with renal cell carcinoma

Presenter: Stefan N. Symeonides
Oncology
State of t
6:13
Title Description

State of the art treatment of bladder cancer

Presenter: Matthew R. Zibelman
Oncology
First-line
7:41
Title Description

First-line pembrolizumab plus chemotherapy versus chemotherapy in advanced esophageal cancer

Presenter: Ken Kato
Oncology
Treatment
3:27
Title Description

Treatment of iron deficiency in acute and chronic heart failure

Presenter: Piotr Ponikowski
Cardiology
Alcohol se
6:32
Title Description

Alcohol septal ablation in hypertrophic cardiomyopathy: past and future

Presenter: Hubert Seggewiss
Cardiology
The use of
3:35
Title Description

The use of SGLT2 inhibitors in the prevention and treatment of heart failure

Presenter: Petar M. Seferovic
Cardiology
Direct myo
5:15
Title Description

Direct myosin inhibitors in hypertrophic cardiomyopathy: a new era?

Presenter: Iacopo Olivotto
Cardiology
Diagnostic
10:55
Title Description

Diagnostic delay in pulmonary arterial hypertension

Presenter: Barbro Kjellström and Bodil Ivarsson
Clinical I
6:21
Title Description

Clinical Impact of Liraglutide as a Treatment of Obesity

Presenter: Babak Dehestani
Internal Medicine
Associatio
20:17
Title Description

Association of GLP 1 Analogs and Agonists Administered for Obesity with Weight Loss and Adverse Events

Presenter: Michael Camilleri
Internal Medicine
Liraglutid
13:26
Title Description

Liraglutide for Weight Management in the Real World

Presenter: Roman Vangoitsenhoven
Cardiology , Diabetology
The role o
10:22
Title Description

The role of GLP-1 receptor agonists in weight reduction and cardiovascular risk reduction

Presenter: Michael A. Nauck
Cardiology , Diabetology